Pfizer Inc [PFE] stock is trading at $26.43, up 4.67%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PFE shares have gain 3.36% over the last week, with a monthly amount glided 6.57%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Wolfe Research started tracking the stock with Underperform rating on November 15, 2024, and set its price target to $25. Bernstein started tracking the stock assigning a Mkt Perform rating and suggested a price target of $32 on October 17, 2024. Daiwa Securities upgraded its rating to a Outperform. Argus downgraded its rating to Hold for this stock on March 22, 2024. In a note dated February 23, 2024, Guggenheim initiated an Buy rating and provided a target price of $36 on this stock.
Pfizer Inc [PFE] stock has fluctuated between $24.48 and $31.54 over the past year. Currently, Wall Street analysts expect the stock to reach $32.83 within the next 12 months. Pfizer Inc [NYSE: PFE] shares were valued at $26.43 at the most recent close of the market. An investor can expect a potential return of 24.21% based on the average PFE price forecast.
Analyzing the PFE fundamentals
Pfizer Inc [NYSE:PFE] reported sales of 60.11B for the trailing twelve months, which represents a growth of 33.78%. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.07%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.05 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.73.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.04 points at the first support level, and at 25.65 for the second support level. However, for the 1st resistance point, the stock is sitting at 26.64, and for the 2nd resistance point, it is at 26.85.
Ratios To Look Out For
For context, Pfizer Inc’s Current Ratio is 1.00. In addition, the Quick Ratio stands at 0.73 and the Cash Ratio stands at 0.03. Considering the valuation of this stock, the price to sales ratio is 2.49, the price to book ratio is 1.62 and price to earnings (TTM) ratio is 35.53.
Transactions by insiders
Recent insider trading involved Gottlieb Scott, Director, that happened on Oct 30 ’24 when 1000.0 shares were purchased. SVP & Controller, DAMICO JENNIFER B. completed a deal on Aug 13 ’24 to sell 5154.0 shares.